MERCK & CO. INC. (6MK.DE) Fundamental Analysis & Valuation

FRA:6MK • US58933Y1055

Current stock price

100 EUR
+1 (+1.01%)
Last:

This 6MK.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 6MK.DE Profitability Analysis

1.1 Basic Checks

  • 6MK had positive earnings in the past year.
  • In the past year 6MK had a positive cash flow from operations.
  • 6MK had positive earnings in each of the past 5 years.
  • In the past 5 years 6MK always reported a positive cash flow from operatings.
6MK.DE Yearly Net Income VS EBIT VS OCF VS FCF6MK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

1.2 Ratios

  • With an excellent Return On Assets value of 13.34%, 6MK belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
  • With an excellent Return On Equity value of 34.70%, 6MK belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 19.70%, 6MK belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for 6MK is significantly above the industry average of 14.61%.
Industry RankSector Rank
ROA 13.34%
ROE 34.7%
ROIC 19.7%
ROA(3y)9.43%
ROA(5y)10.79%
ROE(3y)24.21%
ROE(5y)27.67%
ROIC(3y)22.5%
ROIC(5y)20.92%
6MK.DE Yearly ROA, ROE, ROIC6MK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • 6MK's Profit Margin of 28.08% is amongst the best of the industry. 6MK outperforms 86.27% of its industry peers.
  • In the last couple of years the Profit Margin of 6MK has grown nicely.
  • 6MK's Operating Margin of 38.11% is amongst the best of the industry. 6MK outperforms 90.20% of its industry peers.
  • 6MK's Operating Margin has improved in the last couple of years.
  • The Gross Margin of 6MK (78.55%) is better than 82.35% of its industry peers.
  • In the last couple of years the Gross Margin of 6MK has grown nicely.
Industry RankSector Rank
OM 38.11%
PM (TTM) 28.08%
GM 78.55%
OM growth 3Y6.33%
OM growth 5Y9.38%
PM growth 3Y4.66%
PM growth 5Y10.53%
GM growth 3Y4.72%
GM growth 5Y2.48%
6MK.DE Yearly Profit, Operating, Gross Margins6MK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 6MK.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 6MK is creating value.
  • Compared to 1 year ago, 6MK has less shares outstanding
  • 6MK has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 6MK is higher compared to a year ago.
6MK.DE Yearly Shares Outstanding6MK.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
6MK.DE Yearly Total Debt VS Total Assets6MK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • 6MK has an Altman-Z score of 3.97. This indicates that 6MK is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 3.97, 6MK perfoms like the industry average, outperforming 56.86% of the companies in the same industry.
  • The Debt to FCF ratio of 6MK is 3.99, which is a good value as it means it would take 6MK, 3.99 years of fcf income to pay off all of its debts.
  • 6MK's Debt to FCF ratio of 3.99 is in line compared to the rest of the industry. 6MK outperforms 58.82% of its industry peers.
  • 6MK has a Debt/Equity ratio of 0.89. This is a neutral value indicating 6MK is somewhat dependend on debt financing.
  • The Debt to Equity ratio of 6MK (0.89) is worse than 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 3.99
Altman-Z 3.97
ROIC/WACC2.18
WACC9.04%
6MK.DE Yearly LT Debt VS Equity VS FCF6MK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • 6MK has a Current Ratio of 1.54. This is a normal value and indicates that 6MK is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of 6MK (1.54) is better than 60.78% of its industry peers.
  • A Quick Ratio of 1.30 indicates that 6MK should not have too much problems paying its short term obligations.
  • 6MK has a better Quick ratio (1.30) than 72.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.3
6MK.DE Yearly Current Assets VS Current Liabilites6MK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 6MK.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.16% over the past year.
  • 6MK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.13% yearly.
  • Looking at the last year, 6MK shows a small growth in Revenue. The Revenue has grown by 1.31% in the last year.
  • 6MK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.38% yearly.
EPS 1Y (TTM)20.16%
EPS 3Y7.06%
EPS 5Y9.13%
EPS Q2Q%21.51%
Revenue 1Y (TTM)1.31%
Revenue growth 3Y3.12%
Revenue growth 5Y9.38%
Sales Q2Q%4.97%

3.2 Future

  • 6MK is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.29% yearly.
  • 6MK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.66% yearly.
EPS Next Y-43.62%
EPS Next 2Y3.58%
EPS Next 3Y6.11%
EPS Next 5Y2.29%
Revenue Next Year3.06%
Revenue Next 2Y4.26%
Revenue Next 3Y5.09%
Revenue Next 5Y2.66%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
6MK.DE Yearly Revenue VS Estimates6MK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
6MK.DE Yearly EPS VS Estimates6MK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. 6MK.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.59, the valuation of 6MK can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of 6MK indicates a somewhat cheap valuation: 6MK is cheaper than 76.47% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of 6MK to the average of the S&P500 Index (25.23), we can say 6MK is valued rather cheaply.
  • 6MK is valuated rather expensively with a Price/Forward Earnings ratio of 22.33.
  • 6MK's Price/Forward Earnings ratio is in line with the industry average.
  • 6MK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.42.
Industry RankSector Rank
PE 12.59
Fwd PE 22.33
6MK.DE Price Earnings VS Forward Price Earnings6MK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 6MK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 6MK is cheaper than 70.59% of the companies in the same industry.
  • 6MK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 23.11
EV/EBITDA 10.38
6MK.DE Per share data6MK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • 6MK has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.38
EPS Next 2Y3.58%
EPS Next 3Y6.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. 6MK.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.98%, 6MK has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.90, 6MK pays a bit more dividend than its industry peers.
  • 6MK's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.98%

5.2 History

  • The dividend of 6MK has a limited annual growth rate of 5.92%.
Dividend Growth(5Y)5.92%
Div Incr Years8
Div Non Decr Years8
6MK.DE Yearly Dividends per share6MK.DE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 6MK pays out 44.79% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • 6MK's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP44.79%
EPS Next 2Y3.58%
EPS Next 3Y6.11%
6MK.DE Yearly Income VS Free CF VS Dividend6MK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
6MK.DE Dividend Payout.6MK.DE Dividend Payout, showing the Payout Ratio.6MK.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

6MK.DE Fundamentals: All Metrics, Ratios and Statistics

MERCK & CO. INC.

FRA:6MK (3/23/2026, 4:58:41 PM)

100

+1 (+1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-03
Earnings (Next)04-30
Inst Owners81.17%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap247.24B
Revenue(TTM)65.01B
Net Income(TTM)18.25B
Analysts77.78
Price Target108.2 (8.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.98%
Yearly Dividend2.83
Dividend Growth(5Y)5.92%
DP44.79%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.02%
Min EPS beat(2)2.98%
Max EPS beat(2)13.06%
EPS beat(4)4
Avg EPS beat(4)6.66%
Min EPS beat(4)2.93%
Max EPS beat(4)13.06%
EPS beat(8)8
Avg EPS beat(8)6.19%
EPS beat(12)12
Avg EPS beat(12)16.34%
EPS beat(16)16
Avg EPS beat(16)14.5%
Revenue beat(2)2
Avg Revenue beat(2)0.57%
Min Revenue beat(2)0.31%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)0.83%
Revenue beat(8)6
Avg Revenue beat(8)0.46%
Revenue beat(12)9
Avg Revenue beat(12)1.15%
Revenue beat(16)13
Avg Revenue beat(16)1.9%
PT rev (1m)8.75%
PT rev (3m)18.18%
EPS NQ rev (1m)10.51%
EPS NQ rev (3m)-162.36%
EPS NY rev (1m)-4.35%
EPS NY rev (3m)-45.49%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE 12.59
Fwd PE 22.33
P/S 4.39
P/FCF 23.11
P/OCF 17.34
P/B 5.43
P/tB 65.73
EV/EBITDA 10.38
EPS(TTM)7.94
EY7.94%
EPS(NY)4.48
Fwd EY4.48%
FCF(TTM)4.33
FCFY4.33%
OCF(TTM)5.77
OCFY5.77%
SpS22.76
BVpS18.41
TBVpS1.52
PEG (NY)N/A
PEG (5Y)1.38
Graham Number57.36
Profitability
Industry RankSector Rank
ROA 13.34%
ROE 34.7%
ROCE 22.83%
ROIC 19.7%
ROICexc 22.75%
ROICexgc 46.78%
OM 38.11%
PM (TTM) 28.08%
GM 78.55%
FCFM 19.01%
ROA(3y)9.43%
ROA(5y)10.79%
ROE(3y)24.21%
ROE(5y)27.67%
ROIC(3y)22.5%
ROIC(5y)20.92%
ROICexc(3y)25.76%
ROICexc(5y)23.99%
ROICexgc(3y)53.32%
ROICexgc(5y)52.7%
ROCE(3y)26.06%
ROCE(5y)24.23%
ROICexgc growth 3Y-4.44%
ROICexgc growth 5Y2.75%
ROICexc growth 3Y0.21%
ROICexc growth 5Y7.95%
OM growth 3Y6.33%
OM growth 5Y9.38%
PM growth 3Y4.66%
PM growth 5Y10.53%
GM growth 3Y4.72%
GM growth 5Y2.48%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 3.99
Debt/EBITDA 1.53
Cap/Depr 70.44%
Cap/Sales 6.33%
Interest Coverage 19.06
Cash Conversion 53.81%
Profit Quality 67.71%
Current Ratio 1.54
Quick Ratio 1.3
Altman-Z 3.97
F-Score5
WACC9.04%
ROIC/WACC2.18
Cap/Depr(3y)81.72%
Cap/Depr(5y)99.16%
Cap/Sales(3y)6%
Cap/Sales(5y)6.91%
Profit Quality(3y)892.79%
Profit Quality(5y)570.74%
High Growth Momentum
Growth
EPS 1Y (TTM)20.16%
EPS 3Y7.06%
EPS 5Y9.13%
EPS Q2Q%21.51%
EPS Next Y-43.62%
EPS Next 2Y3.58%
EPS Next 3Y6.11%
EPS Next 5Y2.29%
Revenue 1Y (TTM)1.31%
Revenue growth 3Y3.12%
Revenue growth 5Y9.38%
Sales Q2Q%4.97%
Revenue Next Year3.06%
Revenue Next 2Y4.26%
Revenue Next 3Y5.09%
Revenue Next 5Y2.66%
EBIT growth 1Y1.98%
EBIT growth 3Y9.65%
EBIT growth 5Y19.64%
EBIT Next Year-19.93%
EBIT Next 3Y10.24%
EBIT Next 5Y4.83%
FCF growth 1Y-31.7%
FCF growth 3Y-5.63%
FCF growth 5Y16.24%
OCF growth 1Y-23.27%
OCF growth 3Y-4.81%
OCF growth 5Y9.95%

MERCK & CO. INC. / 6MK.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MERCK & CO. INC.?

ChartMill assigns a fundamental rating of 6 / 10 to 6MK.DE.


What is the valuation status for 6MK stock?

ChartMill assigns a valuation rating of 4 / 10 to MERCK & CO. INC. (6MK.DE). This can be considered as Fairly Valued.


What is the profitability of 6MK stock?

MERCK & CO. INC. (6MK.DE) has a profitability rating of 9 / 10.


What are the PE and PB ratios of MERCK & CO. INC. (6MK.DE) stock?

The Price/Earnings (PE) ratio for MERCK & CO. INC. (6MK.DE) is 12.59 and the Price/Book (PB) ratio is 5.43.


Is the dividend of MERCK & CO. INC. sustainable?

The dividend rating of MERCK & CO. INC. (6MK.DE) is 5 / 10 and the dividend payout ratio is 44.79%.